期刊文献+

重症肌无力中白介素4、15、18与端粒酶活性的相关性研究 被引量:8

The correlation between interleukin-4,15 as well as 18 and telomerase activity in myasthenia gravis
下载PDF
导出
摘要 目的:探讨IL-4、IL-15、IL-18在重症肌无力(MG)中的表达及其与CD4+T淋巴细胞端粒酶活性的相关关系。方法:应用ELISA及重复扩增-酶联免疫吸附实验(PCR-ELISA)检测30例MG患者(MG组)和30例健康对照者(NC组)血清中的IL-4、IL-15、IL-18水平和CD4+T淋巴细胞端粒酶活性。结果:MG组血清IL-4、IL-15、IL-18水平及CD4+T淋巴细胞端粒酶活性显著高于NC组,差异具有统计学意义(P<0.01);MG组CD4+T淋巴细胞端粒酶活性与血清IL-4、IL-15、IL-18水平均存在正相关关系(P<0.01)。结论:IL-4、IL-15、IL-18及CD4+T淋巴细胞端粒酶均参与了MG的发病过程;MG中IL-4、IL-15及IL-18有可能通过各种途径直接或间接的上调CD4+T淋巴细胞的端粒酶的活性。 Objective: To detect the serum levels of IL-4, IL-15 and IL-18 in myasthenia gravis(MG) and investigate the correlations between telomerase activity of CD4+ T lymphocytes and these interleukins. Methods: The serum levels of IL-4, IL-15 and IL-18 were detected with ELISA and telomerase activity was detected by polymerase chain reaction enzyme-linked immonosorbent assay(PCR-ELISA) in 30 MG pa- tients and 30 negative controls. Results: The levels of IL-4, IL-15, IL- 18 and telomerase of CD4+ T lymphocytes in MG were significantly higher than those in negative controls (P 〈 0.01 ). There were positive correlations between the serum levels of IL-4, IL-15, IL-18 and telomerase activity of CD4+ + T cell in MG patients (P 〈 0.01 ). Conclusion: IL-4, IL-15, IL-18 and telomerase activity of CD4 + T lymphocytes are involved in the pathogenesis of MG; IL-4, IL-15 and IL-18 may upregulate the telomerase activity of CD4+ T cells.
作者 陈敏 莫雪安
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2009年第11期1006-1008,共3页 Chinese Journal of Immunology
关键词 重症肌无力 白介素4 白介素15 白介素18 端粒酶 Myasthenia gravis(MG) IL-4 IL-15 IL-18 Telomerase
  • 相关文献

参考文献10

  • 1Li Y, Zhi W, Wareski Pet al. IL-15 activates telomerase and minimizes telomere loss and may preserve the replicative life span of memory CD8^+ T cells in vitro[J].J Immunol,2005; 174(7):4019-4024.
  • 2Kamchunski P I, Ostlie N S, Okita D K et al. Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4^+ epitope sequences of the acetylcholine receptor[ J]. J Neuroimmunol, 1999 ; 95 (13) : 73-84.
  • 3Steinberger I, Brenner T M, Lorberboum galski H et al. Interleukin 2 pseudomonas exotoxin chimeric protein kills B cells from paticnts with myasthenia gravis[ J]. Cell Immunol, 1996; 169 (1) :55-61.
  • 4Stegall T, Krolick K A. Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by upregulating interleukin-15 :an interferon-gamma activator with the potential to influence the severity and course of experimental myas/henia gravis[ J]. J Neuro Immunol, 2001 ; 119(2) : 377-386.
  • 5Nan-ping Weng. Regulation of telomerase expression in human lymphocytes [ J ]. Springer Semin Immunopathol, 2002; 24 (3) : 23-33.
  • 6Kaltoft K. Cytoklne-driven immortalization of in vitro activated human T lymphocytes. CD28 expression correlates inversely with cell popuiauon doublings[ J ]. Exp Clin Immunogenet, 1998 ; 15 (2) : 84-89.
  • 7Yoshimoto T, Tsutsui H, Tominaga K et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils[J]. Proc Natl Acad Sci USA, 1999;96(24) : 13962-13966.
  • 8Kawauchi K, lhjima K, Yamada O. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3, -kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells [ J ]. J Immunol, 2005; 174 (9) :5261-5269.
  • 9Akiyama M,Hideshima T, Hayashi T et al.Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein[ J ]. Cancer Res, 2003 ;63 ( 1 ) : 18-21.
  • 10S zyper-Kravitz M, Uziel O, Shapiro H et al. Granulocyte colony -stimulating factor administration upregulates telomerase activity in CD34^+ haematopoietie cells and may prevent telomere attrition after chemotherapy[J]. Br J Haematol,2003 ; 120(2) :329-336.

同被引文献109

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部